Managing the risk associated with use of contrast media for computed tomography

European Journal of Radiology

Volumn 62, Issue SUPPL., 2007, Pages 33-37

  Stacul, Fulvio ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Computed tomography (CT); Contrast induced nephropathy (CIN); Iodinated contrast media

Indexed keywords

ALLERGIES; DEHYDRATION; DRUG PRODUCTS; MEDICAL IMAGING; PATIENT MONITORING;

CONTRAST-INDUCED NEPHROPATHY (CIN); IODINATED CONTRAST MEDIA;

COMPUTERIZED TOMOGRAPHY;

CONTRAST MEDIUM;

AGE DISTRIBUTION; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DEHYDRATION; ERYTHEMA; HUMAN; KIDNEY FUNCTION; MACULOPAPULAR RASH; NEPHROTOXICITY; PRIORITY JOURNAL; RISK ASSESSMENT; URTICARIA;

EID: 34248592411     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2007.02.022     Document Type: Article

References (37)

1. Maitino A.J., Levin D.C., Parker L., Rao V.M., and Sunshine J.H. Nationwide trends in rates of utilization of noninvasive diagnostic imaging among the Medicare population between 1993 and 1999. Radiology 227 (2003) 113-117
2. Toms A.P., Cash C.J., Linton S.J., and Dixon A.K. Requests for body computed tomography: increasing workload, increasing indications and increasing age. Eur Radiol 11 (2001) 2633-2637
3. Morcos S.K., Thomsen H.S., and Webb J.A. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9 (1999) 1602-1613
4. Lee J.K., Warshauer D.M., Bush Jr. W., et al. Determination of serum creatinine level before intravenous administration of iodinated contrast medium. A survey. Invest Radiol 30 (1995) 700-705
5. Choyke P.L., Cady J., DePollar S.L., and Austin H. Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients?. Tech Urol 4 (1998) 65-69
6. Thomsen H.S., and Morcos S.K. In which patients should serum creatinine be measured before iodinated contrast medium administration?. Eur Radiol 15 (2005) 749-754
7. Bartholomew B.A., Harjai K.J., Dukkipati S., et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93 (2004) 1515-1519
8. Mehran R., Aymong E.D., Nikolsky E., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44 (2004) 1393-1399
9. Thomsen H.S., and Morcos S.K. Management of acute adverse reactions to contrast media. Eur Radiol 14 (2004) 476-481
10. Thomsen H.S. Guidelines for contrast media from the European Society of Urogenital Radiology. Am J Roentgenol 181 (2003) 1463-1471
11. Mueller C., Buerkle G., Buettner H.J., et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162 (2002) 329-336
12. Trivedi H.S., Moore H., Nasr S., et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93 (2003) C29-C34
13. Merten G.J., Burgess W.P., Gray L.V., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291 (2004) 2328-2334
14. Birck R., Krzossok S., Markowetz F., Schnulle P., van der Woude F.J., and Braun C. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362 (2003) 598-603
15. Fishbane S., Durham J.H., Marzo K., and Rudnick M. N-Acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 15 (2004) 251-260
16. Ix J.H., McCulloch C.E., and Chertow G.M. Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis. Nephrol Dial Transplant 19 (2004) 2747-2753
17. Erley C.M., Duda S.H., Rehfuss D., et al. Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant 14 (1999) 1146-1149
18. Huber W., Ilgmann K., Page M., et al. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study. Radiology 223 (2002) 772-779
19. Berg K.J. Nephrotoxicity related to contrast media. Scand J Urol Nephrol 34 (2000) 317-322
20. Barrett B.J., and Carlisle E.J. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188 (1993) 171-178
21. Rudnick M.R., and Goldfarb S. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality. Rev Cardiovasc Med 4 Suppl. 5 (2003) S28-S33
22. Harris K.G., Smith T.P., Cragg A.H., and Lemke J.H. Nephrotoxicity from contrast material in renal insufficiency: ionic versus nonionic agents. Radiology 179 (1991) 849-852
23. Aspelin P., Aubry P., Fransson S.G., Strasser R., Willenbrock R., and Berg K.J. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348 (2003) 491-499
24. Chalmers N., and Jackson R.W. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol 72 (1999) 701-703
25. Gruberg L., Mintz G.S., Mehran R., et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36 (2000) 1542-1548
26. Taliercio C.P., Vlietstra R.E., Fisher L.D., and Burnett J.C. Risks for renal dysfunction with cardiac angiography. Ann Intern Med 104 (1986) 501-504
27. Ferrone M. Pharmacotherapeutic options to prevent radiocontrast-induced acute renal failure. Formulary 39 (2004) 163-185
28. Cavusoglu E., Chhabra S., Marmur J.D., Kini A., and Sharma S.K. The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Minerva Cardioangiol 52 (2004) 419-432
29. Vogt B., Ferrari P., Schonholzer C., et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 111 (2001) 692-698
30. Morcos S.K., Thomsen H.S., and Webb J.A. Prevention of generalized reactions to contrast media: a consensus report and guidelines. Eur Radiol 11 (2001) 1720-1728
31. Katayama H., Yamaguchi K., Kozuka T., Takashima T., Seez P., and Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175 (1990) 621-628
32. Maddox T.G. Adverse reactions to contrast material: recognition, prevention, and treatment. Am Fam Physician 66 (2002) 1229-1234
33. Shehadi W.H., and Toniolo G. Adverse reactions to contrast media: a report from the Committee on Safety of Contrast Media of the International Society of Radiology. Radiology 137 (1980) 299-302
34. Webb J.A., Stacul F., Thomsen H.S., and Morcos S.K. Late adverse reactions to intravascular iodinated contrast media. Eur Radiol 13 (2003) 181-184
35. Christiansen C., Pichler W.J., and Skotland T. Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations. Eur Radiol 10 (2000) 1965-1975
36. van der Molen A.J., Thomsen H.S., and Morcos S.K. Effect of iodinated contrast media on thyroid function in adults. Eur Radiol 14 (2004) 902-907
37. Thomsen H.S., and Morcos S.K. Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media. ESUR Contrast Media Safety Committee. Eur Radiol 9 (1999) 738-740